규제 업데이트
2026년 9월 15일•1분 읽기
FDA Approves Sun Pharm ANDA077373 for Octreotide Acetate Injectable Products
FDA granted approval for Sun Pharm's ANDA077373 covering two discontinued octreotide acetate injectable products, with labeling updates approved in 2013 and 2017.
규제 업데이트
2026년 9월 3일•1분 읽기
FDA Approves Fresenius Kabi’s OCTREOTIDE Acetate Injectable (ANDA 077457)
The FDA has granted approval for Fresenius Kabi USA’s preservative‑free OCTREOTIDE acetate injectable products under ANDA 077457, covering three dosage strengths for injection.
규제 업데이트
2026년 8월 30일•1분 읽기
FDA Approves ANDA076330 for Octreotide Acetate Injection
The FDA has approved application ANDA076330 for octreotide acetate injectable products manufactured by Hikma Pharmaceuticals, available in two dosage strengths.
1